{
    "xml": "<topic id=\"PHP2971\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/tiagabine\" basename=\"tiagabine\" title=\"TIAGABINE\">\n<title>TIAGABINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_857\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/tiagabine\">Tiagabine</xref>\n</p>\n<data name=\"vtmid\">108403006</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_926692410\" title=\"Antiepileptics\">Antiepileptics</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP51530\" outputclass=\"indicationsAndDose\" rev=\"1.19\" parent=\"/drugs/tiagabine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive treatment for focal seizures with or without secondary generalisation that are not satisfactorily controlled by other antiepileptics (with enzyme-inducing drugs)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 5&#8211;10&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10&#8239;mg/24 hours every 1&#8239;week; maintenance 30&#8211;45&#8239;mg daily in 2&#8211;3 divided doses.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8211;10&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10&#8239;mg/24 hours every 1&#8239;week; maintenance 30&#8211;45&#8239;mg daily in 2&#8211;3 divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive treatment for focal seizures with or without secondary generalisation that are not satisfactorily controlled by other antiepileptics (without enzyme-inducing drugs)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 5&#8211;10&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10&#8239;mg/24 hours every 1&#8239;week; maintenance 15&#8211;30&#8239;mg daily in 2&#8211;3 divided doses.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8211;10&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10&#8239;mg/24 hours every 1&#8239;week; maintenance 15&#8211;30&#8239;mg daily in 2&#8211;3 divided doses.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51620\" outputclass=\"cautions\" rev=\"1.23\" parent=\"/drugs/tiagabine\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<p>\r\n<ph outputclass=\"caution\">Avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>\r\n</p>\r\n </section>\r\n<section outputclass=\"importantAdvice\">\r\n<title>Cautions, further information</title>\r\n<sectiondiv>\r\n<p>Tiagabine should be avoided in absence, myoclonic, tonic and atonic seizures due to risk of seizure exacerbation.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP51527\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/tiagabine\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (tiagabine).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51469\" outputclass=\"sideEffects\" rev=\"1.9\" parent=\"/drugs/tiagabine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">emotional lability</ph>; <ph outputclass=\"sideEffect\">impaired concentration</ph>; <ph outputclass=\"sideEffect\">nervousness</ph>; <ph outputclass=\"sideEffect\">speech impairment</ph>; <ph outputclass=\"sideEffect\">tiredness</ph>; <ph outputclass=\"sideEffect\">tremor</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Bruising</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">non-convulsive status epilepticus</ph>; <ph outputclass=\"sideEffect\">psychosis</ph>; <ph outputclass=\"sideEffect\">suicidal ideation</ph>; <ph outputclass=\"sideEffect\">visual disturbances</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Leucopenia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51575\" outputclass=\"hepaticImpairment\" parent=\"/drugs/tiagabine\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>In mild to moderate impairment reduce dose, prolong the dose interval, or both.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51506\" outputclass=\"patientAndCarerAdvice\" rev=\"1.19\" parent=\"/drugs/tiagabine\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n<section outputclass=\"adviceAroundDrivingAndOtherTasks\">\r\n<title>Driving and skilled tasks</title>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Driving</p>\r\n<p>May impair performance of skilled tasks (e.g. driving).</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Tiagibine for preventing seizures</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/tiagabine-for-preventing-seizures\">www.medicinesforchildren.org.uk/tiagabine-for-preventing-seizures</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP2971-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/tiagabine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76183\" title=\"Tablet\" namespace=\"/drugs/tiagabine/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78230\" namespace=\"/treatment-summaries/epilepsy\" title=\"Epilepsy\" count=\"5\" rel=\"backlink\">Epilepsy</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_857\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/tiagabine\" title=\"Tiagabine\" count=\"1\" rel=\"link\">Tiagabine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76183\" namespace=\"/drugs/tiagabine/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP2971",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/tiagabine",
    "basename": "tiagabine",
    "title": "TIAGABINE",
    "interactants": [
        {
            "id": "bnf_int_857",
            "label": "Tiagabine"
        }
    ],
    "vtmid": "108403006",
    "drugClassification": [
        "Antiepileptics"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Adjunctive treatment for focal seizures with or without secondary generalisation that are not satisfactorily controlled by other antiepileptics (with enzyme-inducing drugs)",
                        "html": "Adjunctive treatment for focal seizures with or without secondary generalisation that are not satisfactorily controlled by other antiepileptics (with enzyme-inducing drugs)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 5&#8211;10 mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10 mg/24 hours every 1 week; maintenance 30&#8211;45 mg daily in 2&#8211;3 divided doses.",
                        "html": "<p>Initially 5&#8211;10&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10&#8239;mg/24 hours every 1&#8239;week; maintenance 30&#8211;45&#8239;mg daily in 2&#8211;3 divided doses.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 5&#8211;10 mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10 mg/24 hours every 1 week; maintenance 30&#8211;45 mg daily in 2&#8211;3 divided doses.",
                        "html": "<p>Initially 5&#8211;10&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10&#8239;mg/24 hours every 1&#8239;week; maintenance 30&#8211;45&#8239;mg daily in 2&#8211;3 divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunctive treatment for focal seizures with or without secondary generalisation that are not satisfactorily controlled by other antiepileptics (without enzyme-inducing drugs)",
                        "html": "Adjunctive treatment for focal seizures with or without secondary generalisation that are not satisfactorily controlled by other antiepileptics (without enzyme-inducing drugs)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 5&#8211;10 mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10 mg/24 hours every 1 week; maintenance 15&#8211;30 mg daily in 2&#8211;3 divided doses.",
                        "html": "<p>Initially 5&#8211;10&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10&#8239;mg/24 hours every 1&#8239;week; maintenance 15&#8211;30&#8239;mg daily in 2&#8211;3 divided doses.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 5&#8211;10 mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10 mg/24 hours every 1 week; maintenance 15&#8211;30 mg daily in 2&#8211;3 divided doses.",
                        "html": "<p>Initially 5&#8211;10&#8239;mg daily in 1&#8211;2 divided doses, then increased in steps of 5&#8211;10&#8239;mg/24 hours every 1&#8239;week; maintenance 15&#8211;30&#8239;mg daily in 2&#8211;3 divided doses.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Avoid in Acute porphyrias",
                "html": "Avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "Tiagabine should be avoided in absence, myoclonic, tonic and atonic seizures due to risk of seizure exacerbation.",
                "html": "<p>Tiagabine should be avoided in absence, myoclonic, tonic and atonic seizures due to risk of seizure exacerbation.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (tiagabine).",
                "html": "<p>Appendix 1 (tiagabine).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Diarrhoea",
                        "html": "Diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "emotional lability",
                        "html": "emotional lability",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "impaired concentration",
                        "html": "impaired concentration",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nervousness",
                        "html": "nervousness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "speech impairment",
                        "html": "speech impairment",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tiredness",
                        "html": "tiredness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Bruising",
                        "html": "Bruising",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "non-convulsive status epilepticus",
                        "html": "non-convulsive status epilepticus",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "psychosis",
                        "html": "psychosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "suicidal ideation",
                        "html": "suicidal ideation",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "visual disturbances",
                        "html": "visual disturbances",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Leucopenia",
                        "html": "Leucopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "In mild to moderate impairment reduce dose, prolong the dose interval, or both.",
                "html": "<p>In mild to moderate impairment reduce dose, prolong the dose interval, or both.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in severe impairment.",
                "html": "<p>Avoid in severe impairment.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundDrivingAndOtherTasks": [
            {
                "type": "adviceAroundDrivingAndOtherTasks",
                "title": "Driving",
                "textContent": "May impair performance of skilled tasks (e.g. driving).",
                "html": "<p>May impair performance of skilled tasks (e.g. driving).</p>"
            }
        ],
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/tiagabine-for-preventing-seizures",
                        "label": "www.medicinesforchildren.org.uk/tiagabine-for-preventing-seizures"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Tiagibine for preventing seizures",
                "textContent": "www.medicinesforchildren.org.uk/tiagabine-for-preventing-seizures",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/tiagabine-for-preventing-seizures\">www.medicinesforchildren.org.uk/tiagabine-for-preventing-seizures</xref>\n</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76183",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78230",
                "label": "Epilepsy",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_857",
                "label": "Tiagabine",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76183",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}